Sarepta shares soar after upgrade implies 322% upside By: CNBC.com News May 02, 2016 at 13:00 PM EDT Sarepta Therapeutics shares soared Monday after the stock was upgraded to "outperform" at Oppenheimer. Read More >> Related Stocks: Sarepta Therapeutics